Stay updated with breaking news from Optune Gio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NovoCure Limited (NASDAQ:NVCR – Get Free Report) has been given a consensus rating of “Moderate Buy” by the nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 12 […]
CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of the cancer experience.
(BPT) - Some people just know how to live. One great example is Mike Hugo, who learns from stumbles and turns them into victory — tackling anything he wants to do with vigor and perseverance. …
Novocure today announced that research on Tumor Treating Fields therapy, including new data from the phase 2 2-THE-TOP trial and real-world evidence from patients diagnosed with glioblastoma and...